Clinical trial
Study to Determine Effective Dosing of Fondaparinux in Obese Persons
NCT00346879 · Indiana University School of Medicine, Other · Withdrawn
Key facts
| NCT number | NCT00346879 |
|---|---|
| Title | Study to Determine Effective Dosing of Fondaparinux in Obese Persons |
| Official title | Thromboprophylaxis in the Morbidly Obese With Weight Based Dosing of Fondaparinux: A Pharmacodynamic Study |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | American Society for Bariatric Surgery |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Morbid Obesity |
| Intervention type | Drug |
| Interventions | fondaparinux |
| Enrollment | 0 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Jun 30, 2006 |
| Last update posted | Feb 23, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: